Exhibit 99.2

             VCA Antech, Inc. Provides Financial Guidance

    LOS ANGELES--(BUSINESS WIRE)--Feb. 21, 2006--Our company, VCA
Antech, Inc. (NASDAQ:WOOF), a leading animal healthcare company in the
United States, provides financial guidance for all investors in
adherence with Regulation Fair Disclosure as issued by the United
States Securities and Exchange Commission, the SEC. We encourage all
current and potential investors to review the disclosure regarding
forward-looking statements in this press release as well as in all
financial documents filed with the SEC.
    We are providing the following financial guidance for the year
ending December 31, 2006:

    --  Revenue of $943 million to $962 million;

    --  Laboratory internal revenue growth to a range of 7% to 9%;

    --  Animal hospital same-store revenue growth to a range of 3% to
        5%;

    --  Animal hospital acquired revenue of $30 million to $35
        million;

    --  Medical technology revenue of $32 million to $37 million;

    --  Operating income of $174 million to $179 million;

    --  Net income of $88 million to $90 million; and

    --  Diluted earnings per common share of $1.03 to $1.06.

    The 2006 guidance reflects $0.02 per diluted common share in
expense for share-based compensation resulting from the application of
SFAS No. 123R, which we adopted on January 1, 2006, based on options
outstanding as of December 31, 2005.

    Forward-Looking Statements

    This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including our financial guidance for the fourth quarter of 2005 and
our preliminary guidance for 2006. Such statements are just
predictions and involve risks and uncertainties such that actual
results and performance may differ materially. Factors that might
cause such a difference include: a material adverse change in our
financial condition or operations; the rate of our laboratory internal
revenue growth and animal hospital same-store revenue growth; the
level of direct costs and our ability to maintain revenue at a level
necessary to maintain expected operating margins; the level of
selling, general and administrative costs; the effects of competition;
any impairment in the carrying value of our goodwill; the effects of
our recent acquisitions, including Pet's Choice, and our ability to
effectively manage our growth and achieve expected operating
synergies; changes in prevailing interest rates; our ability to
service our debt; and general economic conditions. These and other
risk factors are discussed in our periodic reports filed with the SEC,
including our Report on Form 10-K for the year ended December 31,
2004, and our periodic Report on Form 10-Q for the quarter ended
September 30, 2005, and the reader is directed to these statements for
a further discussion of important factors that could cause actual
results to differ materially from those in the forward-looking
statements.
    We own, operate and manage the largest networks of freestanding
veterinary hospitals and veterinary-exclusive clinical laboratories in
the country, and we supply ultrasound and digital radiography
equipment to the veterinary industry.


    CONTACT: VCA Antech, Inc.
             Tomas Fuller, 310-571-6505